secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0000950170-23-031482
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 1.02, 2.03, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight refinances debt: $20M new loan at lower rate, extends maturity to 2028
------------------------------------------------------------------------------

- Sold 834,748 common shares via ATM for $19.4M net proceeds; used $20M to repay existing debt.
- New $20M loan from Oxford Finance at floating rate ~11.5% vs prior ~14.0%, saving ~$1.7M in H2 2023 interest.
- Added up to $40M in additional borrowing capacity in four tranches through H1 2025, subject to revenue milestones.
- Principal payments deferred to Aug 2026 (or Aug 2027 if IP not pledged) vs previous Apr 2025; maturity extended to Jun 2028.
- Final payment fee of 5% of original principal; negative pledge on intellectual property.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/0000950170-23-031482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/rxst-20230630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-031482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer